These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38112068)

  • 1. Systematic review of the impact of health care expenditure on health outcome measures: implications for cost-effectiveness thresholds.
    Gloria MAJ; Thavorncharoensap M; Chaikledkaew U; Youngkong S; Thakkinstian A; Chaiyakunapruk N; Ochalek J; Culyer AJ
    Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):203-215. PubMed ID: 38112068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
    Ochalek J; Lomas J
    Clin Ther; 2020 Jan; 42(1):44-59.e2. PubMed ID: 31955967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the efficiency path to universal health coverage: cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures.
    Pichon-Riviere A; Drummond M; Palacios A; Garcia-Marti S; Augustovski F
    Lancet Glob Health; 2023 Jun; 11(6):e833-e842. PubMed ID: 37202020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating a cost-effectiveness threshold for health care decision-making in South Africa.
    Edoka IP; Stacey NK
    Health Policy Plan; 2020 Jun; 35(5):546-555. PubMed ID: 32125375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Systematic Review of Demand-Side Methods of Estimating the Societal Monetary Value of Health Gain.
    Gloria MAJ; Thavorncharoensap M; Chaikledkaew U; Youngkong S; Thakkinstian A; Culyer AJ
    Value Health; 2021 Oct; 24(10):1423-1434. PubMed ID: 34593165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Informing a cost-effectiveness threshold for Saudi Arabia.
    Al-Jedai AH; Lomas J; Almudaiheem HY; Al-Ruthia YSH; Alghamdi S; Awad N; Alghamdi A; Alowairdhi MA; Alabdulkarim H; Almadi M; Bunyan RF; Ochalek J
    J Med Econ; 2023; 26(1):128-138. PubMed ID: 36576804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of health systems strengthening interventions in improving maternal and child health in low- and middle-income countries: a systematic review.
    Zeng W; Li G; Ahn H; Nguyen HTH; Shepard DS; Nair D
    Health Policy Plan; 2018 Mar; 33(2):283-297. PubMed ID: 29253136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Country-Level Cost-Effectiveness Thresholds: Initial Estimates and the Need for Further Research.
    Woods B; Revill P; Sculpher M; Claxton K
    Value Health; 2016 Dec; 19(8):929-935. PubMed ID: 27987642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Effectiveness Threshold for Healthcare: Justification and Quantification.
    Yanovskiy M; Levy ON; Shaki YY; Zigdon A; Socol Y
    Inquiry; 2022; 59():469580221081438. PubMed ID: 35549935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On what basis are medical cost-effectiveness thresholds set? Clashing opinions and an absence of data: a systematic review.
    Cameron D; Ubels J; Norström F
    Glob Health Action; 2018; 11(1):1447828. PubMed ID: 29564962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for the estimation of the National Institute for Health and Care Excellence cost-effectiveness threshold.
    Claxton K; Martin S; Soares M; Rice N; Spackman E; Hinde S; Devlin N; Smith PC; Sculpher M
    Health Technol Assess; 2015 Feb; 19(14):1-503, v-vi. PubMed ID: 25692211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimating cost-effectiveness thresholds under a managed healthcare system: experiences from Colombia.
    Espinosa O; Rodríguez-Lesmes P; Orozco L; Ávila D; Enríquez H; Romano G; Ceballos M
    Health Policy Plan; 2022 Mar; 37(3):359-368. PubMed ID: 34875689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use and Misuse of Cost-Effectiveness Analysis Thresholds in Low- and Middle-Income Countries: Trends in Cost-per-DALY Studies.
    Leech AA; Kim DD; Cohen JT; Neumann PJ
    Value Health; 2018 Jul; 21(7):759-761. PubMed ID: 30005746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds.
    Daroudi R; Akbari Sari A; Nahvijou A; Faramarzi A
    Cost Eff Resour Alloc; 2021 Feb; 19(1):7. PubMed ID: 33541364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of studies eliciting willingness-to-pay per quality-adjusted life year: does it justify CE threshold?
    Nimdet K; Chaiyakunapruk N; Vichansavakul K; Ngorsuraches S
    PLoS One; 2015; 10(4):e0122760. PubMed ID: 25855971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.
    Ekpu VU; Brown AK
    Tob Use Insights; 2015; 8():1-35. PubMed ID: 26242225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global Patterns of QALY and DALY Use in Surgical Cost-Utility Analyses: A Systematic Review.
    Rios-Diaz AJ; Lam J; Ramos MS; Moscoso AV; Vaughn P; Zogg CK; Caterson EJ
    PLoS One; 2016; 11(2):e0148304. PubMed ID: 26862894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation.
    Stinton C; Jordan M; Fraser H; Auguste P; Court R; Al-Khudairy L; Madan J; Grammatopoulos D; Taylor-Phillips S
    Health Technol Assess; 2021 Jun; 25(42):1-216. PubMed ID: 34169821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.
    Edney LC; Haji Ali Afzali H; Cheng TC; Karnon J
    Pharmacoeconomics; 2018 Feb; 36(2):239-252. PubMed ID: 29273843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.